A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study
Condition: Knee Osteoarthritis Interventions: Drug: glucosamine sulphate 1500mg and meloxicam 15mg; Drug: Glucosamine sulfate 1500mg and chondroitin sulfate 1200mg; Drug: Placebos Sponsor: Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2019 Category: Research Source Type: clinical trials
Maximizing Outcomes in Treating Acute Migraine
Condition: Migraine Interventions: Drug: AXS-07 (MoSEIC meloxicam and rizatriptan); Drug: Meloxicam; Drug: Rizatriptan; Drug: Placebo Sponsor: Axsome Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2019 Category: Research Source Type: clinical trials